TCL Archive Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal December 16, 2011
TCL Archive OMB Revisions Would Kill 16 Center core Grants, Ban New Ones, Slash Noncompeting Funds 10 Percent April 15, 1983